The association of echocardiographic parameters on renal outcomes in chronic kidney disease

References

• Hwang SJ, Lin MY, Chen HC, et al. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Nephrol Dial Transplant. 2008;23(10):3192–3198.
   PubMed Web of Science ®Google Scholar
• O’Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18(10):2758–2765.
   PubMed Web of Science ®Google Scholar
• Perkins RM, Bucaloiu ID, Kirchner HL, et al. GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(8):1879–1886.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Li S, Wang C, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010;55(3):S23–S33.
   PubMed Web of Science ®Google Scholar
• Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S79–S91.
   PubMed Web of Science ®Google Scholar
• Stewart GA, Gansevoort RT, Mark PB, et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 2005;67(1):217–226.
   PubMed Web of Science ®Google Scholar
• Hickson LJ, Negrotto SM, Onuigbo M, et al. Echocardiography criteria for structural heart disease in patients with end-stage renal disease initiating hemodialysis. J Am Coll Cardiol. 2016;67(10):1173–1182.
   PubMed Web of Science ®Google Scholar
• Matsuo H, Dohi K, Machida H, et al. Echocardiographic assessment of cardiac structural and functional abnormalities in patients with end-stage renal disease receiving chronic hemodialysis. Circ J. 2018;82(2):586–595.
   PubMed Web of Science ®Google Scholar
• Park M, Hsu C, Li Y, et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol . 2012;23(10):1725–1734.
   PubMed Web of Science ®Google Scholar
• Chen SC, Su HM, Hung CC, et al. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(12):2750–2758.
   PubMed Web of Science ®Google Scholar
• Paoletti E, Bellino D, Gallina AM, et al. Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease? Nephrol Dial Transplant. 2011;26(2):670–677.
   PubMed Web of Science ®Google Scholar
• Furukawa M, Io H, Tanimoto M, et al. Predictive factors associated with the period of time before initiation of hemodialysis in CKD stages 4 and 5. Nephron Clin Pract. 2011;117(4):c341–347.
   PubMedGoogle Scholar
• Shlipak MG, Katz R, Kestenbaum B, et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis. 2009;204(1):298–303.
   PubMed Web of Science ®Google Scholar
• Cioffi G, Tarantini L, Frizzi R, et al. Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. J Hypertens. 2011;29:565–573.
   PubMed Web of Science ®Google Scholar
• Nardi E, Palermo A, Mule G, et al. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens. 2009;27:633–641.
   PubMed Web of Science ®Google Scholar
• Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015;28(7):727–754.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Facchetti R, Bombelli M, et al. Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: data from the PAMELA population. Am J Hypertens. 2014;27(8):1079–1086.
   PubMed Web of Science ®Google Scholar
• Palmieri V, de Simone G, Roman MJ, et al. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension. 1999;34(5):1032–1040.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Benedetto FA, Mallamaci F, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol. 2001;12:2768–2774.
   PubMed Web of Science ®Google Scholar
• Initiative KDOQ. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.
   PubMed Web of Science ®Google Scholar
• Teichholz L, Kreulen T, Herman M, et al. Problems in echocardiographic volume: echocardiographicangiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976;37(1):7–11.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458.
   PubMed Web of Science ®Google Scholar
• de Simone G, Devereux RB, Kimball TR, et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension. 1998;31(5):1077–1082.
   PubMed Web of Science ®Google Scholar
• Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imag. 2015;16(6):577–605.
   PubMed Web of Science ®Google Scholar
• Vickery S, Stevens PE, Dalton RN, et al. Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol Dial Transplant. 2006;21(9):2439–2445.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–470.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Katz R, Kestenbaum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009;20(12):2625–2630.
   PubMed Web of Science ®Google Scholar
• Levey AS, Lesley AS, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Chan MY, Wong HB, Ong HY, et al. Prognostic value of left atrial size in chronic kidney disease. Eur J Echocardiogr. 2008;9(6):736–740.
   PubMed Web of Science ®Google Scholar
• Tripepi G, Benedetto FA, Mallamaci F, et al. Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens. 2006;24:1173–1180.
   PubMed Web of Science ®Google Scholar
• Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006;47(12):2357–2363.
   PubMed Web of Science ®Google Scholar
• Kim BS, Jeon DS, Shin MJ, et al. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis. Am J Nephrol. 2005;25(3):189–195.
   PubMed Web of Science ®Google Scholar
• Vaziri SM, Larson MG, Lauer MS, et al. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension. 1995;25(6):1155–1160.
   PubMed Web of Science ®Google Scholar
• Xu JZ, Wu SY, Yan YQ, et al. Left atrial diameter, flow-mediated dilation of brachial artery and target organ damage in Chinese patients with hypertension. J Hum Hypertens. 2012;26(1):41–47.
   PubMed Web of Science ®Google Scholar
• Todaro MC, Choudhuri I, Belohlavek M, et al. New echocardiographic techniques for evaluation of left atrial mechanics. Eur Heart J Cardiovasc Imag. 2012;13(12):973–984.
   PubMed Web of Science ®Google Scholar
• Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90(12):1284–1289.
   PubMed Web of Science ®Google Scholar
• Kizer JR, Bella JN, Palmieri V, et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J. 2006;151(2):412–418.
   PubMed Web of Science ®Google Scholar
• Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation. 2010;121(23):2592–2600.
   PubMed Web of Science ®Google Scholar
• Ronco C, Ronco F. Cardio-renal syndromes: a systematic approach for consensus definition and classification. Heart Fail Rev. 2012;17(2):151–160.
   PubMed Web of Science ®Google Scholar
• Di Lullo L, Gorini A, Russo D, et al. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med. 2015;5(4):254–266.
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Salvetti M, Monteduro C, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004;43(4):731–738.
   PubMed Web of Science ®Google Scholar
• Palatini P, Visentin P, Mormino P, et al. Left ventricular performance in the early stages of systemic hypertension. HARVEST Study Group. Hypertension and Ambulatory Recording Venetia Study. Am J Cardiol. 1998;81(4):418–423.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Smith G, Gerdts E, et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol. 2000;85(4):466–472.
   PubMed Web of Science ®Google Scholar
• Hassan MO, Duarte R, Dix-Peek T, et al. Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients. Cardiorenal Med. 2016;86(S1):131–135.
   Google Scholar
• Liao Y, Cooper RS, Durazo-Arvizu R, et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol. 1997;29(3):641–647.
   PubMed Web of Science ®Google Scholar
• Ritz E. Heart and kidney: fatal twins? Am J Med. 2006;119(5 Suppl 1):S31–S39.
   PubMed Web of Science ®Google Scholar
• Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27(3):347–354.
   PubMed Web of Science ®Google Scholar
• Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999;34(1):125–134.
   PubMed Web of Science ®Google Scholar
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389.
   PubMed Web of Science ®Google Scholar
• Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341(17):1276–1283.
   PubMed Web of Science ®Google Scholar
• de Simone G, Kitzman DW, Palmieri V, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study. Am J Hypertens. 2004;17(9):828–833.
   PubMed Web of Science ®Google Scholar
• Mureddu GF, Pasanisi F, Palmieri V, et al. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. J Hypertens. 2001;19:1113–1119.
   PubMed Web of Science ®Google Scholar
• de Simone G, Palmieri V, Koren MJ, et al. Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension. J Hypertens. 2001;19:119–125.
   PubMed Web of Science ®Google Scholar
• de Simone G, Verdecchia P, Pede S, et al. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension. 2002;40(4):470–476.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Wachtell K, Omvik P, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension. 2007;49(2):311–316.
   PubMed Web of Science ®Google Scholar